• English
  • Português
  • Español

Immunoglobulin Use in the Neonatal Period: A Clinical Schematic of Indications, Dosing, and Pathways

Cover page showing a neonate under phototherapy lights in an incubator with the title Immunoglobulin Use in the Neonatal Period: A Clinical Schematic of Indications, Dosing, and Pathways.

Immunoglobulin Use in the Neonatal Period

A Clinical Schematic of Indications, Dosing, and Pathways

Neonatal Immunoglobulins Overview

Diagram categorizing neonatal immunoglobulins into Standard Human IVIG and Specific Hyperimmune Globulins with their indications, plus a warning about IVIG in neonatal sepsis, over a background image of antibodies and a virus particle.

Neonatal Immunoglobulins

  • Standard Human IVIG — Broad immune modulation
    • Indications: Isoimmune Haemolytic Anaemia (Jaundice) & Neonatal Allo-immune Thrombocytopenia (NAIT)
  • Specific Hyperimmune Globulins — Targeted post-exposure prophylaxis
    • Indications: Hepatitis B (HBIG) & Varicella Zoster (VZIG)

Clinical Caveat: IVIG has no proven benefit in substantive trials as an adjunctive therapy for routine neonatal sepsis.

Hematology Protocol: Isoimmune Haemolytic Anaemia (Jaundice)

Flowchart of the hematology protocol for isoimmune haemolytic anaemia jaundice showing context, intervention, decision criteria, and IVIG dosing at 500 mg/kg, alongside a screenshot of the Neofast app medicine entry screen.

Hematology Protocol: Isoimmune Haemolytic Anaemia (Jaundice)

  • Context: At-Risk Neonate: Rhesus (D, c, C, E, e), Kell, or Duffy incompatibility.
  • Intervention: Intensive Phototherapy Active (4 light sources at correct distance).
  • Decision: Is Bilirubin rising at >8.5 µmol/L per hour? OR Hb 100-120 g/L with rapidly rising bilirubin close to exchange levels.
  • Action: Initiate Standard IVIG — 500 mg/kg, administered via IV over 4 hours.

Repeat Dose? A single repeat dose can be given >12 hours later ONLY if bilirubin continues to rise rapidly.

App Reference: Neofast Medicines Screen

  • Medicine: Human immunoglobulin
  • Product: Immunoglobulin®
  • Route: Intermittent IV
  • Concentration: 50mg/mL Solution
  • Fields: Weight (kg), Desired dose (mg/kg/dose)
  • Additional information / Bibliographical references link available

Neofast App: Dosing Calculation Example

Two smartphone screenshots of the Neofast app showing dosing calculation for human immunoglobulin at 500 mg/kg for a 2 kg infant, including infusion rate breakdown over time.

Neofast App: Human Immunoglobulin Dosing Calculation

  • Medicine: Human immunoglobulin
  • Product: Immunoglobulin®
  • Route: Intermittent IV
  • Concentration: 50mg/mL Solution
  • Weight (kg): 2
  • Desired dose (mg/kg/dose): 500
  • Suggested dose: 400 to 1000 mg/kg/dose
ParameterValue
Dose1,000mg
IntervalAMD
Dose20mL

Infusion Rate

DurationVolume
30min0.6mL
30min1.2mL
30min1.8mL
30min3.6mL
1h50min12.8mL

Note: The infusion rate used was 0.01 mL/kg/min for the first 30 min, followed by 0.02 mL/kg/min for the next 30 min and 0.03 mL/kg/day for another 30 minutes and ending with 0.06 mL/kg/min for the remainder of the dose (as recommended by the manufacturer). The recommended dose in Neofax for isoimmune hemolytic disease is 0.5 to 1 g/kg/dose, which can be repeated in 12 hours AMD; neonatal alloimmune thrombocytopenia is 1 g/kg/dose IV every day for 2 doses and in measles exposure is 400 mg/kg/dose IV within 6 days of…

Hematology Protocol: Neonatal Allo-immune Thrombocytopenia (NAIT)

Protocol diagram for NAIT showing context, bleeding and non-bleeding triggers for IVIG, dosing at 1 g/kg/day, and two Neofast app screenshots showing dosing and infusion rate calculations.

Hematology Protocol: Neonatal Allo-immune Thrombocytopenia (NAIT)

Context: Severe thrombocytopenia in an otherwise healthy term newborn is NAIT until proven otherwise.

Triggers for IVIG +/- steroids

  • Bleeding: Platelet count < 50 x 10^9/L AND severe haemorrhage persists despite antigen-negative platelet transfusion.
  • Non-Bleeding: Platelet count < 25 x 10^9/L (whether actively bleeding or not).

Dosing & Administration

  • Dose: 1 g/kg/day
  • Route: IV
  • Duration: Once daily for 1 to 3 days.

Note: May require additional doses 2-4 weeks later due to persistence of maternal antibodies.

App Reference: Neofast Dosing Example

ParameterValue
Dose2,000mg
IntervalAMD
Dose40mL

Infusion Rate

DurationVolume
30min0.6mL
30min1.2mL
30min1.8mL
30min3.6mL
4h40min32.8mL
  • Medicine: Human immunoglobulin
  • Product: Immunoglobulin®
  • Route: Intermittent IV
  • Concentration: 50mg/mL Solution
  • Weight (kg): 2
  • Desired dose (mg/kg/dose): 1000
  • Suggested dose: 400 to 1000 mg/kg/dose

Infection Prophylaxis: Hepatitis B (HBIG) and Varicella Zoster (VZIG)

Infographic detailing Hepatitis B immunoglobulin (HBIG) timing and dosing of 250 units IM within 24 hours of birth, and a table for Varicella Zoster immunoglobulin (VZIG) exposure types, triggers, timing, and dosing of 250 mg IV.

Infection Prophylaxis: Hepatitis B (HBIG)

HBIG must be administered within 24 hours of birth (absolute maximum 7 days).

  • Timeline: Birth → 24 Hours (solid, required) → 7 days (dashed, absolute maximum)

Given alongside Hep B Vaccine to:

  • Low-birth-weight babies (<=1.5 kg) born to a Hep B positive mother (regardless of HBeAg status)
  • Babies born to highly infectious mothers.

Dose: 250 units IM

Procedural Note: Use 2 separate injection sites for the vaccine and HBIG. For LBW babies, the 250 unit HBIG dose can be divided into smaller amounts across different sites.

Infection Prophylaxis: Varicella Zoster (VZIG)

Exposure TypeTriggerTimingDosing Box
Maternal ExposureMother develops chickenpox rash 7 days before to 7 days after birth.Give ASAP (within 72 hours for antenatal exposure; within 10 days for postnatal).250 mg (~1.7 mL), Route: IV
Non-Maternal ExposureVZ IgG-negative babies exposed in the first 7 days, OR exposed babies requiring intensive/prolonged care (e.g., <28 weeks or <1 kg)Give ASAP (within 10 days of exposure)250 mg (~1.7 mL), Route: IV

Alternative Exception: If VZIG is unavailable or IM is contraindicated, give 0.2 g/kg of standard IVIG (Note: this is less effective)

Synthesis: The Bedside Immunoglobulin Matrix & Aftercare Protocols

Summary table of all four neonatal immunoglobulin indications with dose, route, and timing, followed by three columns detailing aftercare and follow-up protocols for jaundice, NAIT, and Hepatitis B exposure.

Synthesis: The Bedside Immunoglobulin Matrix

IndicationProductDoseRouteTiming / Duration
Haemolytic JaundiceStandard IVIG500 mg/kgIV (over 4 hrs)Single dose (repeat >12h if needed)
NAITStandard IVIG1 g/kg/dayIVOnce daily for 1-3 days
Hepatitis B ExposureHBIG250 unitsIMWithin 24 hours of birth
Varicella ExposureVZIG250 mgIVASAP (within 72h to 10 days)

Crucial Aftercare & Follow-Up Protocols

Post-IVIG for Jaundice

  • Mandatory ongoing neurodevelopmental follow-up.
  • Audiology/Hearing test required.
  • Check Hb every 2 weeks initially, and until 3 months of age (vital due to the risk of late anaemia).

Post-IVIG for NAIT

  • Recheck platelet count 2 weeks post-discharge.
  • Note: A subset of babies require a second course of IVIG if maternal antibodies persist.

Post-HBIG for Hep B

  • Monitor babies <28 weeks’ gestation for 72 hours post-administration.
  • Strict respiratory monitoring required during this window to detect adverse cardiopulmonary events.
Closing branding page featuring the Neofast logo with a fetus icon over a virus and antibody illustration, with App Store and Google Play download badges.

Neofast

Download on the App Store and Get it on Google Play